Synthetic mRNA therapy: Study introduces weapon against metastatic cancer without harmful side effects
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...
ZME Science on MSN20h
Finally, mRNA vaccines against cancer are starting to become a reality
RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
EurekAlert!3d
Synthetic mRNA therapy: A new weapon against metastatic cancer
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...
Post falsely claims Trump bans Covid-19 mRNA vaccines
Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...
NKyTribune3d
Expert says COVID-19 mRNA vaccine is ‘safe and effective,’ as Senate Bill 177 languishes
By Kushi Arora Kentucky Health News A bill that would have banned schools and workplaces from requiring a COVID-19 vaccine or ...
Mirage News2d
Synthetic mRNA Therapy Tackles Metastatic Cancer
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...
EurekAlert!10d
FLIpping the Switch: Boosting stem cell numbers for therapies
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce ...
Fierce Biotech3d
AstraZeneca goes in vivo, penning $1B deal for Belgian off-the-shelf cell therapy biotech
AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...
Clinical Trials Arena on MSN13d
Everest Medicines begins dosing in mRNA cancer vaccine trial
Everest Medicines has dosed the first subject with EVM16, the company’s personalised mRNA cancer vaccine, in the EVM16CX01 ...
Moderna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...
Morningstar7d
Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 13, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases ...